Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001521536-11-000197
Filing Date
2011-09-09
Accepted
2011-09-09 15:02:49
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 q1100147_10qa-biozone.htm 10-Q/A 28691
  Complete submission text file 0001521536-11-000197.txt   1110716

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE bzne-20110630.xml EX-101.INS 145400
3 XBRL SCHEMA FILE bzne-20110630.xsd EX-101.SCH 10694
4 XBRL CALCULATION FILE bzne-20110630_cal.xml EX-101.CAL 27456
5 XBRL DEFINITION FILE bzne-20110630_def.xml EX-101.DEF 7763
6 XBRL LABEL FILE bzne-20110630_lab.xml EX-101.LAB 82275
7 XBRL PRESENTATION FILE bzne-20110630_pre.xml EX-101.PRE 58279
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-146182 | Film No.: 111083296
SIC: 7389 Services-Business Services, NEC